GADSDEN REPORT
Don't Tread On The Truth
Economy & Markets

Moderna stock prices double on claimed mRNA cancer vaccine breakthrough

Source: EXAMINER 5 views 0 comments
Moderna's new mRNA cancer vaccine to treat melanoma met key marks in late-stage clinical trials, causing its stock prices to double. Read more at EXAMINER ›
Read the full story at
EXAMINER
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to EXAMINER, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Why portfolio managers struggle to beat the market [EXAMINER]
United Arab Emirates suspends trade with Iran after latest attack [EXAMINER]
Amazon plans massive expansion of Prime Air drone deliveries [FOX BIZ]
Trump’s new oil rule is a $750 billion taxpayer scam [EXAMINER]
Texas cities dominate America's best housing markets as coastal powerhouses fall behind: report [FOX BIZ]
What the odd July jobs report means for the Fed [EXAMINER]

Discussion — 0 comments

No comments yet. Be the first.